Grössmann, N. and Wild, C. (2016): Horizon Scanning in Oncology: Results of the 26th Prioritisation – 1st quarter 2016. HSO: 26th Prioritisation.
|PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader|
For the 26th prioritisation (March 2016), 12 drugs were filtered out of 224 identified and were sent to prioritisation. Of these, 2 drugs were ranked as "highly relevant" by the expert panel, 9 as "relevant" and 1 as "not relevant". For "highly relevant" drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.
|Item Type:||DSD: Horizon Scanning in Oncology|
|Subjects:||WB Practice of medicine > WB 300-962 Therapeutics|
QZ Pathology > QZ 200-380 Neoplasms.Cysts
|Series Name:||HSO: 26th Prioritisation|
|Deposited on:||22 Apr 2016 12:32|
|Last Modified:||05 Aug 2016 19:44|
Repository Staff Only: item control page